MyMetro helps you save all your important health information in one place. Select the topics that interest you to stay up-to-date with what's happening at Metro. You can also access your medical records, contact your physician, and pay your bill online! Sign up today!

In an emergency, seconds count. If you are alarmed by unusually severe symptoms, seek immediate care. Please call 911 if you feel your condition is life threatening. If a poison is involved, please call Grand Rapids Poison Control Center at (800) 222-1222.

Metro Health Newsroom

Welcome to the Metro Health Newsroom, where you can find current releases, photos, facts, figures and more. If you can't find what you're looking for, please call or e-mail and we'll be glad to help you out. We take patient confidentiality very seriously and follow all HIPAA guidelines.

Important Information About a Pharmaceutical Recall

Previously Released by Sanofi US:

Sanofi US is voluntarily recalling all Auvi-Q® (epinephrine injection, USP). The recall involves all Auvi-Q currently on the market and includes both the 0.15 mg and 0.3 mg strengths for hospitals, retailers and consumers. This includes lot numbers 2081278 through 3037230, which expire October 2015 through December 2016.The products have been found to potentially have inaccurate dosage delivery, which may include failure to deliver drug.

If a patient experiencing a serious allergic reaction (i.e., anaphylaxis) did not receive the intended dose, there could be significant health consequences, including death because anaphylaxis is a potentially life threatening condition. As of October 26, 2015, Sanofi has received 26 reports of suspected device malfunctions in the US and Canada. None of these device malfunction reports have been confirmed. In these reports, patients have described symptoms of the underlying hypersensitivity reaction. No fatal outcomes have been reported among these cases.

Auvi-Q (epinephrine injection, USP) is used to treat life threatening allergic reactions (anaphylaxis) in people who are at risk for or have a history of these reactions. Auvi-Q is packaged with two active devices and one trainer device in a corrugate box. Auvi-Q was distributed throughout the United States via wholesalers, pharmacies and hospitals. All Auvi-Q is being recalled.

Sanofi US is notifying its distributors and customers who include doctors, pharmacies, wholesalers and other customers in the supply chain by letter, fax, email and phone calls and is arranging for return and reimbursement of all recalled products.

Customers with questions regarding this recall can go to www.AuviQ.com and call 1-877-319-8963 or 1-866-726-6340 Monday through Friday 8 a.m. to 8 p.m. ET for information about how to return their Auvi-Q devices. Customers may also email cs@sanofi.com (mailto:cs@sanofi.com). Sanofi US will provide reimbursement for out of pocket costs incurred for the purchase of new epinephrine auto-injectors with proof of purchase. In addition, if you purchased Auvi-Q at a cost that exceeds the cost of your replacement device, Sanofi will compensate you for the difference, with proof of original and replacement product purchases.

Customers should immediately contact their healthcare provider (HCP) for a prescription for an alternate epinephrine auto-injector. In the event of a life threatening allergic reaction (anaphylaxis), patients should only use their Auvi-Q device if another epinephrine auto-injector is not available, and then call 911 or local medical emergency services. Customers should contact their physician or HCP if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Sanofi US is committed to patient safety and the quality of Auvi-Q, and will continue to work closely with customers and regulatory authorities to resolve this issue in a timely manner.

Important Safety Information

Auvi-Q is for immediate self (or caregiver) administration and does not take the place of emergency medical care. Seek immediate medical treatment after use. Each AuviQ contains a single dose of epinephrine. Auvi-Q should only be injected into your outer thigh. DO NOT INJECT INTO BUTTOCK OR INTRAVENOUSLY. If you accidentally inject Auvi-Q into any other part of your body, seek immediate medical treatment. Epinephrine should be used with caution if you have heart disease or are taking certain medicines that can cause heart-related (cardiac) symptoms.

If you take certain medicines, you may develop serious life-threatening side effects from epinephrine. Be sure to tell your doctor about all the medicines you take, especially medicines for asthma. Side effects may be increased in patients with certain medical conditions, or who take certain medicines. These include asthma, allergies, depression, thyroid disease, Parkinson’s disease, diabetes, high blood pressure, and heart disease.

The most common side effects may include increase in heart rate, stronger or irregular heartbeat, sweating, nausea and vomiting, difficulty breathing, paleness, dizziness, weakness or shakiness, headache, apprehension, nervousness, or anxiety. These side effects go away quickly, especially if you rest.

You are encouraged to report negative side effects of prescription drugs. In the US, contact the FDA by visiting www.fda.gov/medwatch or call 1-800-FDA-1088.

Subscribe

Social Media

Related Content

Events

Family Bonds Cancer Support Group

March 20, 2018
Meet with other cancer patients and their families for dinner and support. Learn More

Go Further with Food: Community Seminar

March 20, 2018
Join us as we celebrate National Nutrition Month! Learn ways to decrease food loss and waste, while being mindful of portion sizes. Discover new and exciting ways to reinvent leftovers, utilize your own pantry and freezer for meal planning and save money! Learn More

Painting Class

March 20, 2018
Let your creative side shine as you are guided step-by-step through painting a masterpiece! All supplies are provided, and you get to take your work of art home with you. Registration is limited and required with payment in advance to reserve your spot. Learn More

Muscles in Motion

March 20, 2018
Get in shape with this total body strength training class! All fitness levels are welcome. Exercise modifications are always shown and a variety of equipment is used, making each class different. Please bring water, an exercise mat and hand weights (3-5 lbs). Learn More

What's Up?

Get Social

News

Grand Rapids Area Hospitals Enhancing Healthy Visitor Efforts

January 24, 2018
The following news advisory is being distributed by the Kent County Health Department on behalf of Spectrum Health, Metro Health – University of Michigan Health, Mercy Health, Mary Free Bed and Pine Rest Christian Mental Health Services. Learn More

Area Hospitals and Public Health Officials Remind Community of Flu Precautions, How and When to Seek Care for Flu

January 11, 2018
Area hospitals, urgent care facilities and doctor offices are experiencing an increase in the number of people presenting with flu and flu-like symptoms. Learn More

Two Local OB/GYN Physicians Move to Metro Health – University of Michigan Health

December 21, 2017
Renee Elderkin, MD, and Susan VandenBosch, MD, began seeing patients at Metro Health on December 18. Learn More